Metropolis Healthcare Q4 FY26 Results: Consolidated PAT Rs 50.90 Crore 2nd Interim Dividend Declared
- May 14, 2026
- Posted by: Neeraj Pandey
- Category: News
Metropolis Healthcare Q4 FY26 results were announced on 13 May 2026. Metropolis Healthcare Q4 FY26 consolidated PAT was Rs 50.90 crore. The company, one of India’s largest diagnostics chains, declared a 2nd interim dividend for FY26 at its Q4 board meeting. Metropolis Healthcare operates a network of diagnostic labs and collection centres across India, serving patients and hospitals. Investors tracking Metropolis Healthcare Q4 FY26 results will find detailed financial data, analysis, and FY27 outlook in this article.
Click Here – Get Free Investment Predictions
Metropolis Healthcare Q4 FY26 Key Financial Highlights
| Parameter | Q4 FY26 | Reference |
|---|---|---|
| Net Profit (PAT) | Rs 50.90 crore | Reference period |
| Dividend | Rs 2nd interim declared per share | Subject to AGM approval |
| NSE Ticker | METROPOLIS | Sector: Diagnostic Services |
Screen the best stocks on the Univest Screener.
Metropolis Healthcare Q4 FY26 Performance Analysis
Metropolis Healthcare Q4 FY26 consolidated PAT was Rs 50.90 crore. The company, one of India’s largest diagnostics chains, declared a 2nd interim dividend for FY26 at its Q4 board meeting. Metropolis Healthcare operates a network of diagnostic labs and collection centres across India, serving patients and hospitals. Investors and analysts will closely monitor management commentary on FY27 revenue outlook, margin trajectory, and capital allocation strategy following these Metropolis Healthcare Q4 FY26 results.
The Metropolis Healthcare Q4 FY26 results represent a strong growth quarter for the company. Track live price, analyst ratings, and earnings updates on the Univest Screener.
Metropolis Healthcare FY27 Outlook
Post Metropolis Healthcare Q4 FY26 results, investor focus for FY27 will be on management guidance, margin trajectory, new order wins or business development, and sector-specific tailwinds. The strong Q4 FY26 performance sets a positive base for FY27 earnings delivery.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on Metropolis Healthcare Q4 FY26 Results
What is Metropolis Healthcare Q4 FY26 net profit?
Ans. Metropolis Healthcare Q4 FY26 net profit is Rs 50.90 crore.
When did Metropolis Healthcare announce Q4 FY26 results?
Ans. Metropolis Healthcare announced Q4 FY26 results on 13 May 2026, through its board meeting and BSE/NSE exchange filings.
What is Metropolis Healthcare Q4 FY26 dividend?
Ans. The board recommended a final dividend of Rs 2nd interim declared per equity share for FY26, subject to shareholder approval at the AGM.
Where can I track Metropolis Healthcare Q4 FY26 live data?
Ans. Track Metropolis Healthcare live price, analyst ratings, and Q4 FY26 earnings updates on the Univest Screener for real-time data and research.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. All financial data cited is sourced from BSE/NSE exchange filings and verified news sources. Investments in securities are subject to market risk. Consult a SEBI-registered investment advisor before making any investment decision.
